RNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment
After transcription, RNAs are always associated with RNA binding proteins (RBPs) to perform biological activities. RBPs can interact with target RNAs in sequence- and structure-dependent manner through their unique RNA binding domains. In development and progression of carcinogenesis, RBPs are aberr...
Saved in:
| Published in | Journal of cancer prevention Vol. 22; no. 4; pp. 203 - 210 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
Korea (South)
Korean Society of Cancer Prevention
01.12.2017
대한암예방학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2288-3649 2288-3657 |
| DOI | 10.15430/JCP.2017.22.4.203 |
Cover
Loading…
| Abstract | After transcription, RNAs are always associated with RNA binding proteins (RBPs) to perform biological activities. RBPs can interact with target RNAs in sequence- and structure-dependent manner through their unique RNA binding domains. In development and progression of carcinogenesis, RBPs are aberrantly dysregulated in many human cancers with various mechanisms, such as genetic alteration, epigenetic change, noncoding RNA-mediated regulation, and post-translational modifications. Upon deregulation in cancers, RBPs influence every step in the development and progression of cancer, including sustained cell proliferation, evasion of apoptosis, avoiding immune surveillance, inducing angiogenesis, and activating metastasis. To develop therapeutic strategies targeting RBPs, RNA interference-based oligonucleotides or small molecule inhibitors have been screened based on reduced RBP-RNA interaction and changed level of target RNAs. Identification of binding RNAs with high-throughput techniques and integral analysis of multiple datasets will help us develop new therapeutic drugs or prognostic biomarkers for human cancers. |
|---|---|
| AbstractList | After transcription, RNAs are always associated with RNA binding proteins (RBPs) to perform biological activities. RBPs can interact with target RNAs in sequence- and structure-dependent manner through their unique RNA binding domains. In development and progression of carcinogenesis, RBPs are aberrantly dysregulated in many human cancers with various mechanisms, such as genetic alteration, epigenetic change, noncoding RNA-mediated regulation, and post-translational modifications. Upon deregulation in cancers, RBPs influence every step in the development and progression of cancer, including sustained cell proliferation, evasion of apoptosis, avoiding immune surveillance, inducing angiogenesis, and activating metastasis. To develop therapeutic strategies targeting RBPs, RNA interference-based oligonucleotides or small molecule inhibitors have been screened based on reduced RBP-RNA interaction and changed level of target RNAs. Identification of binding RNAs with high-throughput techniques and integral analysis of multiple datasets will help us develop new therapeutic drugs or prognostic biomarkers for human cancers. After transcription, RNAs are always associated with RNA binding proteins (RBPs) to perform biological activities. RBPs can interact with target RNAs in sequence- and structure-dependent manner through their unique RNA binding domains. In development and progression of carcinogenesis, RBPs are aberrantly dysregulated in many human cancers with various mechanisms, such as genetic alteration, epigenetic change, noncoding RNA-mediated regulation, and post-translational modifications. Upon deregulation in cancers, RBPs influence every step in the development and progression of cancer, including sustained cell proliferation, evasion of apoptosis, avoiding immune surveillance, inducing angiogenesis, and activating metastasis. To develop therapeutic strategies targeting RBPs, RNA interference-based oligonucleotides or small molecule inhibitors have been screened based on reduced RBP-RNA interaction and changed level of target RNAs. Identification of binding RNAs with high-throughput techniques and integral analysis of multiple datasets will help us develop new therapeutic drugs or prognostic biomarkers for human cancers. KCI Citation Count: 0 After transcription, RNAs are always associated with RNA binding proteins (RBPs) to perform biological activities. RBPs can interact with target RNAs in sequence- and structure-dependent manner through their unique RNA binding domains. In development and progression of carcinogenesis, RBPs are aberrantly dysregulated in many human cancers with various mechanisms, such as genetic alteration, epigenetic change, noncoding RNA-mediated regulation, and post-translational modifications. Upon deregulation in cancers, RBPs influence every step in the development and progression of cancer, including sustained cell proliferation, evasion of apoptosis, avoiding immune surveillance, inducing angiogenesis, and activating metastasis. To develop therapeutic strategies targeting RBPs, RNA interference-based oligonucleotides or small molecule inhibitors have been screened based on reduced RBP-RNA interaction and changed level of target RNAs. Identification of binding RNAs with high-throughput techniques and integral analysis of multiple datasets will help us develop new therapeutic drugs or prognostic biomarkers for human cancers.After transcription, RNAs are always associated with RNA binding proteins (RBPs) to perform biological activities. RBPs can interact with target RNAs in sequence- and structure-dependent manner through their unique RNA binding domains. In development and progression of carcinogenesis, RBPs are aberrantly dysregulated in many human cancers with various mechanisms, such as genetic alteration, epigenetic change, noncoding RNA-mediated regulation, and post-translational modifications. Upon deregulation in cancers, RBPs influence every step in the development and progression of cancer, including sustained cell proliferation, evasion of apoptosis, avoiding immune surveillance, inducing angiogenesis, and activating metastasis. To develop therapeutic strategies targeting RBPs, RNA interference-based oligonucleotides or small molecule inhibitors have been screened based on reduced RBP-RNA interaction and changed level of target RNAs. Identification of binding RNAs with high-throughput techniques and integral analysis of multiple datasets will help us develop new therapeutic drugs or prognostic biomarkers for human cancers. |
| Author | Hong, Suntaek |
| Author_xml | – sequence: 1 givenname: Suntaek surname: Hong fullname: Hong, Suntaek organization: Department of Biochemistry, College of Medicine, Gachon University, Incheon, Korea |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29302577$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002303238$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNpVUMlOwzAQtRCI_Qc4IB_h0OIlju0LUqnKJgQIhQMny3EmxdA4xUmR-HtMKQhOM3rraHbQemgDIHRAyZCKjJOT6_H9kBEqh4wNs7TxNbTNmFIDngu5_rtnegvtd90LIYRykWvNNtEW05wwIeU2enq4HeEzHyofpvg-tj34gG2HbcCTBuL0Cy6eIdo5LHrvcGHjFHpctxGPbXAQkwneIfS-Tb5Q4SKC7ZsE7KGN2s462F_NXfR4PinGl4Obu4ur8ehmEBgn_aDKrdJO1CC0cxWTlctyyLOc01pzJTJJbFkqVVaCUsdImYMAsAqyRObUOb6Ljr9zQ6zNq_OmtX45p615jWb0UFwZxjIihEja02_tfFE2ULl0ZrQzM4--sfFj6fzPBP-cct6NkIIqLlPA0Sogtm8L6HrT-M7BbGYDtIvOUK204JIImqSHf7t-S35-zz8BlF6Jlw |
| ContentType | Journal Article |
| Copyright | Copyright © 2017 Korean Society of Cancer Prevention 2017 |
| Copyright_xml | – notice: Copyright © 2017 Korean Society of Cancer Prevention 2017 |
| DBID | NPM 7X8 5PM ACYCR |
| DOI | 10.15430/JCP.2017.22.4.203 |
| DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2288-3657 |
| EndPage | 210 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_2240555 PMC5751837 29302577 |
| Genre | Journal Article Review |
| GroupedDBID | 5-W 8JR ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL DIK HYE KQ8 M48 NPM OK1 PGMZT RPM 7X8 5PM ACYCR |
| ID | FETCH-LOGICAL-n230t-d6a89c5fe59ccd27dc46e64631f9385470abb88bd511c20b6e5eea8e438561cc3 |
| IEDL.DBID | M48 |
| ISSN | 2288-3649 |
| IngestDate | Sun Mar 09 07:55:14 EDT 2025 Thu Aug 21 18:23:45 EDT 2025 Fri Jul 11 11:30:50 EDT 2025 Wed Feb 19 02:42:19 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | RNA-binding proteins Chemoprevention Therapeutics Cancer |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-n230t-d6a89c5fe59ccd27dc46e64631f9385470abb88bd511c20b6e5eea8e438561cc3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.15430/JCP.2017.22.4.203 |
| PMID | 29302577 |
| PQID | 1989537051 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_2240555 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5751837 proquest_miscellaneous_1989537051 pubmed_primary_29302577 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-Dec 20171201 2017-12 |
| PublicationDateYYYYMMDD | 2017-12-01 |
| PublicationDate_xml | – month: 12 year: 2017 text: 2017-Dec |
| PublicationDecade | 2010 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | Journal of cancer prevention |
| PublicationTitleAlternate | J Cancer Prev |
| PublicationYear | 2017 |
| Publisher | Korean Society of Cancer Prevention 대한암예방학회 |
| Publisher_xml | – name: Korean Society of Cancer Prevention – name: 대한암예방학회 |
| SSID | ssj0001356992 |
| Score | 2.3957481 |
| SecondaryResourceType | review_article |
| Snippet | After transcription, RNAs are always associated with RNA binding proteins (RBPs) to perform biological activities. RBPs can interact with target RNAs in... |
| SourceID | nrf pubmedcentral proquest pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 203 |
| SubjectTerms | Review 예방의학 |
| Title | RNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29302577 https://www.proquest.com/docview/1989537051 https://pubmed.ncbi.nlm.nih.gov/PMC5751837 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002303238 |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 대한암예방학회지, 2017, 22(4), , pp.203-210 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LTxsxELZSuHCpQDyaUiJT9bohWb92DxUKUSMaCYRQIoWTtX5siVI5sAlS---ZcTa0oBw47cH27mo8tj-PP89HyDeL0idp1yZMlHnCnbOJyZVLMLNMtwQv8vGg_epaXo75cCImDbKWO6oNuNi4tUM9qXH1u_3n8e85DPjvUb2Hs87ZsH-DJC3VTtM2xknYB7INK5PCgXpVw_0Yc2FC5lEnOU3BQZjkeX2PZvNrYL0JVbkJe76lUP63Jg12yccaTNLeqvf3SMOHfXJ3e92jF9N4W4XeYBqGaaDFghaBYgQKRYno6N-tKzqKXHAK4JX20QUquk7rNId2wdHRmot-QMaDH6P-ZVILKCQBdhbLxMkiy5FOJnJrXaqc5dJLLlm3zFkmuOoUxmSZcYC6bNox0gvvi8xzKJRda9kh2Qrz4D8RagAHmk4B2y8GcytzWSYs1OCGZbYQrmySr2AqPbNTjQmr8flrrmeVBlj-UyNuEEI0yenakhq8GI8miuDnTwuNzC3BFMwQTXK0sqx-WKXb0ABIAJgp1STqlc1fKuAHX5eE6X3MlB0PlZj6_J6fOyY72PkrqsoXsrWsnvwJAI6laUUvasVI0DMPg9M4 |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=RNA+Binding+Protein+as+an+Emerging+Therapeutic+Target+for+Cancer+Prevention+and+Treatment&rft.jtitle=Journal+of+cancer+prevention&rft.au=%ED%99%8D%EC%84%A0%ED%83%9D&rft.date=2017-12-01&rft.pub=%EB%8C%80%ED%95%9C%EC%95%94%EC%98%88%EB%B0%A9%ED%95%99%ED%9A%8C&rft.issn=2288-3649&rft.eissn=2288-3657&rft.spage=203&rft.epage=210&rft_id=info:doi/10.15430%2FJCP.2017.22.4.203&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_2240555 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2288-3649&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2288-3649&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2288-3649&client=summon |